Optimization and scale-up of solvent extraction in purification of hepatitis A virus (VAQTA™)
✍ Scribed by Anna J. Hagen; Cynthia N. Oliver; Robert D. Sitrin
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 110 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0006-3592
No coin nor oath required. For personal study only.
✦ Synopsis
Solvent extraction is a very powerful purification step in the preparation of VAQTAா, a highly purified, inactivated hepatitis A vaccine. Extraction of an aqueous product-containing protein solution with chloroform through vigorous shaking causes irreversible denaturation of contaminant proteins at the interface. However, the hepatitis A virus (HAV) remains viable and soluble in the aqueous phase. Because three phases (air, aqueous, and organic) are involved, and the mixing is carried out in individual bottles, there is very little theory available to characterize this process, so it must be studied experimentally. This extraction step was characterized by following the removal of a specific impurity from the aqueous phase as a representative marker for the degree of protein precipitation. These experiments led to the identification and optimization of the important variables controlling the extraction step. They were found to be mixing time and size of vessel, with longer mixing times resulting in higher purity and larger bottle size leading to faster kinetics of impurity removal. These parameters are most likely related to solvent/aqueous interfacial area and the resulting shear due to shaking. We conclude that, to scale up this type of mixing, the kinetics of impurity removal need to be determined experimentally for the systems and equipment under consideration.
📜 SIMILAR VOLUMES
## Abstract Accelerated solvent extraction (ASE) has been compared with a Soxhlet extraction for extracting and estimating the concentration of hexahydro‐1,3,5‐trinitro‐__s__‐triazine (RDX) and octahydro‐1,3,5,7‐tetrazocine (HMX) in sediment samples. Extraction of RDX and HMX was studied in terms o
Sera from 79 patients with acute self-limiting hepatitis, 17 patients with acute hepatitis B evolving into chronic HBsAg carriership, and 43 chronic HBsAg carriers without a history of acute hepatitis were analyzed for presence of hepatitis B virus (HBV)-DNA by a molecular hybridization technique. I
Hepatitis B virus (HBV) markers were measured in 83 immunosuppressed renal transplant patients who were followed for periods of 2 to 15 years. Sixty-nine patients were negative for HBsAg before transplantation, of whom 14 were positive for anti-HBs. The remaining 14 patients were HBsAg positive prio
To determine the optimal conditions for preparation of serum specimens for quantitative hepatitis C virus RNA determination, patient samples were processed such that Merences in time from clot formation to centrifugation, centrifugation to separation of serum and collection of serum until freezing c